DPROVSPACB• 7 Days (Normalized)
DPRO vs PACB (Draganfly Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 29 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DPRO Performance $4.9
-20.97%
Draganfly Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+56.83%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin PACB LEADS
-77.8 pts
PACB outperforming by 77.80 percentage points
DPROPACB
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DPRO PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | DPRO Price | DPRO Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $4.90 | -20.97% | $2.87 | +56.83% | -77.80% |
| Oct 02, 2026 | $5.29 | -14.76% | $2.54 | +38.80% | -53.56% |
| Oct 01, 2026 | $- | $2.51 | +37.16% | - | |
| Sep 30, 2026 | $- | $2.37 | +29.51% | - | |
| Sep 29, 2026 | $6.20 | +0.00% | $1.83 | +0.00% | +0.00% |